ACADIA PHARMACEUTICALS INC. (ACAD) Operating income 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual operating income history from SEC filings — each fiscal year as reported.
$104.8MFY2025 · since FY2016: -$272.8M → $104.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.8M | -54.6% |
| FY2024 | $230.8M | +414.5% |
| FY2023 | -$73.4M | +67.2% |
| FY2022 | -$223.6M | -31.2% |
| FY2021 | -$170.4M | +40.5% |
| FY2020 | -$286.6M | -16.2% |
| FY2019 | -$246.5M | +0.4% |
| FY2018 | -$247.4M | +15.4% |
| FY2017 | -$292.4M | -7.2% |
| FY2016 | -$272.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAD financial trends
ACAD RevenueACAD Net incomeACAD Net marginACAD Gross profitACAD Gross marginACAD Operating marginACAD Operating cash flowACAD Free cash flowACAD Capital expendituresACAD Return on equityACAD Stock buybacksACAD Dividends paidACAD Total assetsACAD Total liabilitiesACAD Shareholders’ equityACAD overview →